Skip to content

SLEEP & HEART

Active
Private limited companyfounded 200916 yrs activeGroene Jagerslaan 48, 1180 Ukkel, BelgiumKBO/BCE: BE 0818.751.066

SLEEP & HEART has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €603k and a net result of €81k. Equity is growing by ~7.3% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 1.4% (low).

Checked score

Score 2025
90 / 100
Excellent▼ -3 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability67▼-28
Solvency100=
Growth78=
Stability100
Bankruptcy probability, 12 months
1.4% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55k at 30 days acceptable
Liquidity ample (current ratio 5.87 against 6.27 in 2024), and 16.4% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
83.6%
Return on assets
11.2%
Age of the figures
8 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 16 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-05-2026, 81 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
81 d early
2024
28 d early
2023
55 d early
2022
14 d early
2021
68 d early
2020
26 d early
2019
8 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€603k▼ 4.7%
2024 · €633k
2018: €391k 2019: €413k 2020: €487k 2021: €470k 2022: €530k 2023: €612k 2024: €633k
2018 → 2025
Total assets
€721k▼ 3.2%
2024 · €745k
2018: €397k 2019: €507k 2020: €540k 2021: €622k 2022: €622k 2023: €705k 2024: €745k
2018 → 2025
Net result
€81k▼ 32.5%
2024 · €120k
2018: €76k 2019: €100k 2020: €111k 2021: €112k 2022: €124k 2023: €158k 2024: €120k
2018 → 2025
Working capital
€576k▼ 2.6%
2024 · €591k
2018: €390k 2019: €410k 2020: €485k 2021: €457k 2022: €520k 2023: €562k 2024: €591k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€470k-€530k▲ 12.7%€612k▲ 15.6%€633k▲ 3.3%€603k▼ 4.7%
Operating result€158k-€176k▲ 11.1%€223k▲ 26.9%€157k▼ 29.7%€102k▼ 34.8%
Net result€112k-€124k▲ 10.8%€158k▲ 28.1%€120k▼ 24.5%€81k▼ 32.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200kOperating result 2021: €158k€158kNet result 2021: €112k€112kOperating result 2022: €176k€176kNet result 2022: €124k€124kOperating result 2023: €223k€223kNet result 2023: €158k€158kOperating result 2024: €157k€157kNet result 2024: €120k€120kOperating result 2025: €102k€102kNet result 2025: €81k€81k20212022202320242025
The operating result has fallen two years in a row; 2025 is 35% below 2024 and is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €721k
Fixed assets €27k▼ 34.7%
Current assets €694k▼ 1.4%
Equity and liabilities €721k
Equity €603k▼ 4.7%
Debt €118k▲ 5.3%
The debt ratio rises from 15.1% to 16.4%: debt grows while equity shrinks.
Key figures and ratios
2025 value · change against 2024
EBITDA
€118k
2024 · €172k
Cash flow
€97k
2024 · €135k
Solvency
83.6%
2024 · 84.9%
Current ratio
5.87
2024 · 6.27
Quick ratio
5.87
2024 · 6.27
Debt / equity
0.20
2024 · 0.18
ROE
13.4%
2024 · 18.9%
ROA
11.2%
2024 · 16.1%
Interest coverage
237.58
2024 · 459.56
Debt
€118k
2024 · €112k
Debt ≤ 1 year
€118k
2024 · €112k
Income taxes
€34k
2024 · €51k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€745k€721k
Fixed assets21/28€41k€27k
Tangible fixed assets22/27€41k€27k
Furniture and vehicles24€41k€27k
Current assets29/58€704k€694k
Amounts receivable within one year40/41€31k€44k
Trade receivables40€30k€27k
Other amounts receivable41€402€17k
Current investments50/53€328k€398k
Cash at bank and in hand54/58€342k€249k
Deferred charges and accrued income490/1€3k€3k
Equity and liabilities
Total equity and liabilities10/49€745k€721k
Equity10/15€633k€603k
Contributions10/11€6k€6k=
Reserves13€626k€596k
Distributable reserves133€626k€596k
Profit (loss) carried forward14€352€352=
Amounts payable17/49€112k€118k
Amounts payable within one year42/48€112k€118k
Financial debts43€4k€46
Credit institutions430/8€4k€46
Trade debts44€2k€1k
Suppliers440/4€2k€1k
Taxes, remuneration and social security45€6k€6k
Taxes450/3€6k€6k
Other amounts payable47/48€100k€111k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15k€16k
Other operating charges640/8€1k€878
Gross operating margin9900€173k€119k
Operating profit (loss)9901€157k€102k
Financial income75/76B€15k€13k
Recurring financial income75€15k€13k
Financial charges65/66B€374€496
Recurring financial charges65€374€496
Profit (loss) for the period before taxes9903€171k€115k
Income taxes67/77€51k€34k
Profit (loss) for the period9904€120k€81k
Profit (loss) for the period to be appropriated9905€120k€81k
Appropriation of the result
Profit (loss) to be appropriated9906€120k€81k
Profit (loss) brought forward from the previous period14P€352€352=
Transfer from equity791/2€100k€111k
Transfer to equity691/2€120k€81k
To other reserves6921€120k€81k
Profit to be distributed694/7€100k€111k
Return on contributions (dividend)694€100k€111k

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
11-05
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
03-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
06-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Highest result since 2018net €158k ▲28.1%
Operating result €223k, net result €158k, both a record.
17-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Equity above €500kEq €530k ▲12.7%
5 profitable years in a row build equity to €530k.
24-05
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
05-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
23-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
08-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
17-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
13-07
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2009
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Groene Jagerslaan 481180 Ukkel
Ground area
1,304 m²
Building footprint
328 m²
Volume, LiDAR
2,057 m³
Parcel 21612C0292/00S004, Brussels · tallest building 10.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
SLEEP & HEART
Groene Jagerslaan 48, 1180 UkkelSpecialist medical practice
since 20092.181.187.431
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21612C0292/00S004 Brussels 1,304 m² 1 · 328 m² 10.6 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded22-09-2009
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.